Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
about
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
description
scientific article published on 08 May 2020
@en
name
Triple combination of interfer ...... bel, randomised, phase 2 trial
@en
type
label
Triple combination of interfer ...... bel, randomised, phase 2 trial
@en
prefLabel
Triple combination of interfer ...... bel, randomised, phase 2 trial
@en
P2093
P1433
P1476
Triple combination of interfer ...... bel, randomised, phase 2 trial
@en
P2093
Agnes Yim-Fong Fung
Alan Ka-Lun Wu
Albert Kwok-Wai Lie
Allen Wing-Ho Chu
Alwin Yeung
Anthony Chin-Ki Ng
Anthony Raymond Tam
Chak-Sing Lau
Cyril Chik-Yan Yip
David Christopher Lung
P2536
P356
10.1016/S0140-6736(20)31042-4
P577
2020-05-08T00:00:00Z
P6179
1127497768
P698
P8150
covidwho-209647
covidwho-232479